BYSI Quote, Financials, Valuation and Earnings

Electromed, Inc. has a net margin of -- compared to BeyondSpring, Inc.'s net margin of 12.65%. BeyondSpring, Inc.'s return on equity of -- beat Electromed, Inc.'s return on equity of 18.89%.

BeyondSpring, Inc. has a consensus price target of --, signalling downside risk potential of -32.8%. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 25.31%. Given that Electromed, Inc. has higher upside potential than BeyondSpring, Inc., analysts believe Electromed, Inc. is more attractive than BeyondSpring, Inc..

BeyondSpring, Inc. has a beta of 0.528, which suggesting that the stock is 47.227% less volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.259, suggesting its less volatile than the S&P 500 by 74.113%.

BeyondSpring, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BeyondSpring, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.

BeyondSpring, Inc. quarterly revenues are --, which are smaller than Electromed, Inc. quarterly revenues of $16.9M. BeyondSpring, Inc.'s net income of -$1.7M is lower than Electromed, Inc.'s net income of $2.1M. Notably, BeyondSpring, Inc.'s price-to-earnings ratio is 25.86x while Electromed, Inc.'s PE ratio is 30.91x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BeyondSpring, Inc. is 29.97x versus 3.83x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Myomo, Inc. has a net margin of -- compared to BeyondSpring, Inc.'s net margin of -36.3%. BeyondSpring, Inc.'s return on equity of -- beat Myomo, Inc.'s return on equity of -68.35%.

BeyondSpring, Inc. has a consensus price target of --, signalling downside risk potential of -32.8%. On the other hand Myomo, Inc. has an analysts' consensus of $5.00 which suggests that it could grow by 390.2%. Given that Myomo, Inc. has higher upside potential than BeyondSpring, Inc., analysts believe Myomo, Inc. is more attractive than BeyondSpring, Inc..

BeyondSpring, Inc. has a beta of 0.528, which suggesting that the stock is 47.227% less volatile than S&P 500. In comparison Myomo, Inc. has a beta of 1.026, suggesting its more volatile than the S&P 500 by 2.583%.

BeyondSpring, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BeyondSpring, Inc. pays -- of its earnings as a dividend. Myomo, Inc. pays out -- of its earnings as a dividend.

BeyondSpring, Inc. quarterly revenues are --, which are smaller than Myomo, Inc. quarterly revenues of $10.1M. BeyondSpring, Inc.'s net income of -$1.7M is higher than Myomo, Inc.'s net income of -$3.7M. Notably, BeyondSpring, Inc.'s price-to-earnings ratio is 25.86x while Myomo, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BeyondSpring, Inc. is 29.97x versus 1.00x for Myomo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -- compared to BeyondSpring, Inc.'s net margin of -862.39%. BeyondSpring, Inc.'s return on equity of -- beat VolitionRX Ltd.'s return on equity of --.

BeyondSpring, Inc. has a consensus price target of --, signalling downside risk potential of -32.8%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 773.02%. Given that VolitionRX Ltd. has higher upside potential than BeyondSpring, Inc., analysts believe VolitionRX Ltd. is more attractive than BeyondSpring, Inc..

BeyondSpring, Inc. has a beta of 0.528, which suggesting that the stock is 47.227% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

BeyondSpring, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BeyondSpring, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

BeyondSpring, Inc. quarterly revenues are --, which are smaller than VolitionRX Ltd. quarterly revenues of $627.3K. BeyondSpring, Inc.'s net income of -$1.7M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, BeyondSpring, Inc.'s price-to-earnings ratio is 25.86x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BeyondSpring, Inc. is 29.97x versus 17.27x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -- compared to BeyondSpring, Inc.'s net margin of 3.93%. BeyondSpring, Inc.'s return on equity of -- beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

BeyondSpring, Inc. has a consensus price target of --, signalling downside risk potential of -32.8%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 92.8%. Given that Xtant Medical Holdings, Inc. has higher upside potential than BeyondSpring, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than BeyondSpring, Inc..

BeyondSpring, Inc. has a beta of 0.528, which suggesting that the stock is 47.227% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

BeyondSpring, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BeyondSpring, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

BeyondSpring, Inc. quarterly revenues are --, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. BeyondSpring, Inc.'s net income of -$1.7M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, BeyondSpring, Inc.'s price-to-earnings ratio is 25.86x while Xtant Medical Holdings, Inc.'s PE ratio is 76.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BeyondSpring, Inc. is 29.97x versus 0.85x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.